Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RMD open

Showing results (941-950 of 1,920) with videos related to

Pageof 192
Sort By:
RMD Open|June 24, 2026
No benefit of adding glucocorticoids to maintenance treatment in reducing the risk of major relapses in ANCA-associated vasculitis: real life data from a longitudinal cohort studyKaterina Chavatza, Chrysoula G Gialouri, Konstantinos Drougkas, et al.
RMD Open|June 24, 2026
Effects of biologic and targeted synthetic disease modifying antirheumatic drugs (b/tsDMARDs) on patient-reported outcome domains in rheumatoid arthritis: a systematic review and network meta-analysesLuuk van Esveld, Marijke van den Dikkenberg, Nathalie Luurssen-Masurel, et al.
RMD Open|June 24, 2026
Long-term safety and efficacy of upadacitinib compared with adalimumab in patients with rheumatoid arthritis: 7-year data from the SELECT-COMPARE studyRoy Fleischmann, Jerzy Swierkot, Patrick Durez, et al.
RMD Open|July 15, 2026
Evaluation of the prognostic value of visual and quantitative CT analysis in myositis-associated interstitial lung diseaseSangmee Sharon Bae, Daniela Markovic, Augustine Chung, et al.
RMD Open|July 15, 2026
Serum IgA autoantibody profiling in systemic lupus erythematosus reveals associations with disease phenotypesLaura E Eades, Artemis Papadaki, Katie Lennard, et al.
RMD Open|July 15, 2026
Real-world efficacy and safety of avacopan in ANCA-associated vasculitis: a retrospective comparative studyFranz Thiele, Johanna Schneider, Eric Prager, et al.
RMD Open|April 5, 2016
Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosisJessica Meijs, Anne A Schouffoer, Nina Ajmone Marsan, et al.
RMD Open|November 3, 2022
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapySilje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, et al.
RMD Open|November 3, 2022
Risk of pre-eclampsia and impact of disease activity and antirheumatic treatment in women with rheumatoid arthritis, axial spondylarthritis and psoriatic arthritis: a collaborative matched cohort study from Sweden and DenmarkAnne Emilie Pape Secher, Fredrik Granath, Bente Glintborg, et al.
RMD Open|November 3, 2022
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohortSimon Kuster, Suzana Jordan, Muriel Elhai, et al.
Pageof 192

Showing results (941-950 of 1,920) with videos related to

Sort By:
Pageof 192
RMD Open|June 24, 2026
No benefit of adding glucocorticoids to maintenance treatment in reducing the risk of major relapses in ANCA-associated vasculitis: real life data from a longitudinal cohort studyKaterina Chavatza, Chrysoula G Gialouri, Konstantinos Drougkas, et al.
RMD Open|June 24, 2026
Effects of biologic and targeted synthetic disease modifying antirheumatic drugs (b/tsDMARDs) on patient-reported outcome domains in rheumatoid arthritis: a systematic review and network meta-analysesLuuk van Esveld, Marijke van den Dikkenberg, Nathalie Luurssen-Masurel, et al.
RMD Open|June 24, 2026
Long-term safety and efficacy of upadacitinib compared with adalimumab in patients with rheumatoid arthritis: 7-year data from the SELECT-COMPARE studyRoy Fleischmann, Jerzy Swierkot, Patrick Durez, et al.
RMD Open|July 15, 2026
Evaluation of the prognostic value of visual and quantitative CT analysis in myositis-associated interstitial lung diseaseSangmee Sharon Bae, Daniela Markovic, Augustine Chung, et al.
RMD Open|July 15, 2026
Serum IgA autoantibody profiling in systemic lupus erythematosus reveals associations with disease phenotypesLaura E Eades, Artemis Papadaki, Katie Lennard, et al.
RMD Open|July 15, 2026
Real-world efficacy and safety of avacopan in ANCA-associated vasculitis: a retrospective comparative studyFranz Thiele, Johanna Schneider, Eric Prager, et al.
RMD Open|April 5, 2016
Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosisJessica Meijs, Anne A Schouffoer, Nina Ajmone Marsan, et al.
RMD Open|November 3, 2022
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapySilje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, et al.
RMD Open|November 3, 2022
Risk of pre-eclampsia and impact of disease activity and antirheumatic treatment in women with rheumatoid arthritis, axial spondylarthritis and psoriatic arthritis: a collaborative matched cohort study from Sweden and DenmarkAnne Emilie Pape Secher, Fredrik Granath, Bente Glintborg, et al.
RMD Open|November 3, 2022
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohortSimon Kuster, Suzana Jordan, Muriel Elhai, et al.
Pageof 192